TABLE 2.
Oral fluid CBD concentrations at baseline and ~20‐, ~145‐ and ~185‐min posttreatment on the placebo and the 15‐, 300‐ and 1500‐mg CBD treatments
| Oral fluid CBD concentrations (ng·ml−1) | ||||
|---|---|---|---|---|
| Placebo | 15‐mg CBD | 300‐mg CBD | 1500‐mg CBD | |
| Baseline | <LOQ | <LOQ | <LOQ | <LOQ |
| +20 min | <LOQ | 0.4 (6.0) | 15.8 (41.6) | 167 (233) |
| +145 min | <LOQ | <LOQ (1.6) | 5.4 (10.2) | 77.0 (112) |
| +185 min | <LOQ | <LOQ (0.6) | 1.4 (8.1) | 15.1 (68.7) |
Note: All values are median (IQR).
Abbreviations: CBD, cannabidiol; LOQ, limit of quantification.